Literature DB >> 14203057

RADIOACTIVE YTTRIUM 90: A REVIEW OF ITS PROPERTIES, BIOLOGICAL BEHAVIOR, AND CLINICAL USES.

L A WALKER.   

Abstract

Keywords:  BLADDER NEOPLASMS; CHELATING AGENTS; KIDNEY FUNCTION TESTS; LIVER FUNCTION TESTS; NEOPLASM DIAGNOSIS; NEOPLASM RADIOTHERAPY; PERITONEAL NEOPLASMS; REVIEW; YTTRIUM ISOTOPES

Mesh：

Substances：

Year:  1964        PMID： 14203057     DOI： 10.1080/02841866409134063

Source DB:  PubMed          Journal:  Acta Radiol Ther Phys Biol        ISSN： 0567-8064


× No keyword cloud information.
  4 in total

Review 1.  The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres.

Authors:  Mark A Westcott; Douglas M Coldwell; David M Liu; Joseph F Zikria
Journal:  Adv Radiat Oncol       Date:  2016-08-18

Review 2.  Targeted Therapy With Immunoconjugates for Multiple Myeloma.

Authors:  Wassilis S C Bruins; Sonja Zweegman; Tuna Mutis; Niels W C J van de Donk
Journal:  Front Immunol       Date:  2020-06-19       Impact factor: 7.561

3.  90Y-NM600 targeted radionuclide therapy induces immunologic memory in syngeneic models of T-cell Non-Hodgkin's Lymphoma.

Authors:  Reinier Hernandez; Kirsti L Walker; Joseph J Grudzinski; Eduardo Aluicio-Sarduy; Ravi Patel; Christopher D Zahm; Anatoly N Pinchuk; Christopher F Massey; Ariana N Bitton; Ryan J Brown; Paul M Sondel; Zachary S Morris; Jonathan W Engle; Christian M Capitini; Jamey P Weichert
Journal:  Commun Biol       Date:  2019-02-26

Review 4.  Liver-Directed Therapy for Neuroendocrine Metastases: From Interventional Radiology to Nuclear Medicine Procedures.

Authors:  Roberto Luigi Cazzato; Fabrice Hubelé; Pierre De Marini; Eric Ouvrard; Julien Salvadori; Pietro Addeo; Julien Garnon; Jean-Emmanuel Kurtz; Michel Greget; Luc Mertz; Bernard Goichot; Afshin Gangi; Alessio Imperiale
Journal:  Cancers (Basel)       Date:  2021-12-19       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.